The impact on Phase III trials is particularly significant, as these later-stage studies involve larger, committed patient populations and represent years of investment
She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River
Broadens downstream purification portfolio with next-generation Protein A chromatography for scalable manufacturing
Over the past few months, Apollo Hospitals has entered into MoUs with multiple national and international air ambulance service providers
The open-label trial involved 105 adults with schizophrenia who were on a stable dose of an oral atypical antipsychotic for at least six weeks
The CDMO Leadership Awards spotlight top-performing development and manufacturing service providers
The SCOUT-HCM trial hit its primary endpoint, showing a clinically meaningful and statistically significant reduction in Valsalva left ventricular outflow tract
Sugammadex injection is bioequivalent to Merck’s Bridion injection for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults and pediatric patients aged 2 years and older undergoing surgery
The partnership has already launched with five active development programs, with both organizations jointly managing regulatory strategy and documentation under a structured, milestone-gated framework
Subscribe To Our Newsletter & Stay Updated
